In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) was identified in Wuhan, China. The World Health Organization (WHO) declared this outbreak a significant threat to international health. COVID-19 is highly infectious and can lead to fatal comorbidities especially acute respiratory distress syndrome (ARDS). Thus, fully understanding the characteristics of COVID-19-related ARDS is conducive to early identification and precise treatment. We aimed to describe the characteristics of COVID-19-related ARDS and to elucidate the differences from ARDS caused by other factors. COVID-19 mainly affected the respiratory system with minor damage to other organs. Injury to the alveolar epithelial cells was the main cause of COVID-19-related ARDS, and endothelial cells were less damaged with therefore less exudation. The clinical manifestations were relatively mild in some COVID-19 patients, which was inconsistent with the severity of laboratory and imaging findings. The onset time of COVID-19-related ARDS was 8–12 days, which was inconsistent with ARDS Berlin criteria, which defined a 1-week onset limit. Some of these patients might have a relatively normal lung compliance. The severity was redefined into three stages according to its specificity: mild, mild-moderate, and moderate-severe. HFNO can be safe in COVID-19-related ARDS patients, even in some moderate-severe patients. The more likely cause of death is severe respiratory failure. Thus, the timing of invasive mechanical ventilation is very important. The effects of corticosteroids in COVID-19-related ARDS patients were uncertain. We hope to help improve the prognosis of severe cases and reduce the mortality.
【저자키워드】 COVID-19, coronavirus, acute respiratory distress syndrome, Berlin criteria, 【초록키워드】 Corticosteroid, Treatment, coronavirus disease, ARDS, Mortality, Prognosis, severity, severe respiratory failure, Comorbidity, Laboratory, Health, Characteristics, outbreak, International, Patient, Factors, death, Mild, WHO, Respiratory system, patients, COVID-19 patients, acute respiratory distress, Endothelial cell, Invasive mechanical ventilation, Safe, clinical manifestation, World Health Organization, HFNO, syndrome, other organs, help, Stage, Severe case, ARDS patients, Effect, limit, Wuhan, China, IMPROVE, defined, affected, caused, less, reduce, damaged, alveolar epithelial cell, ARDS patient, moderate-severe, normal lung compliance, the timing, 【제목키워드】 Acute respiratory failure,